Clinical trial
Huaiqihuang Granules in the Treatment of Primary Glomerulonephritis of Stage CKD3: a Randomized, Double-blind, Double-simulation, Positive Parallel Control Multi-center Clinical Study
NCT04263922 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Dalian Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Huaiqihuang Granules in the Treatment of Primary Glomerulonephritis of Stage CKD3: a Randomized, Double-blind, Double-simulation, Positive Parallel Control Multi-center Clinical Study
- Lead sponsor
- The First Affiliated Hospital of Dalian Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 30, 2020
- Completion date
- March 30, 2026
- Enrollment
- 466 (estimated)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.